COVID-19 and the disruption of cancer screening programs: Key lessons for the recovery.

Rabeneck, Linda; Saraiya, Mona

Rabeneck, Linda; Saraiya, Mona.

Rabeneck L; Dalla Lana School of Public Health and Department of Medicine, University of Toronto, and Cancer Care Ontario, Toronto, Canada. Electronic address: Linda.Rabeneck@ontariohealth.ca.
Saraiya M; Division of Cancer Prevention and Control, Epidemiology and Applied Research Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

Prev Med ; 151: 106687, 2021 10.

Article in English | MEDLINE | ID: covidwho-1294333

Subject(s)

COVID-19; Neoplasms; Early Detection of Cancer; Humans; Neoplasms/diagnosis; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study Limits: Humans Language: English Journal: Prev Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google